Extracellular Vesicles Act as Nano-Transporters of Tyrosine Kinase Inhibitors to Revert Iodine Avidity in Thyroid Cancer

A new approach for using extracellular vesicles (EVs) to deliver tyrosine kinase inhibitors (TKIs) to enhance iodine avidity in radioactive iodine-refractory thyroid cancer is needed. We isolated and characterized primary human adipose-derived stem cells (ADSCs) and isolated their EVs. The EVs were...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajendran, Ramya Lakshmi, Paudel, Sanjita, Gangadaran, Prakash, Oh, Ji Min, Oh, Eun Jung, Hong, Chae Moon, Lee, Sangkyu, Chung, Ho Yun, Lee, Jaetae, Ahn, Byeong-Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916551/
https://www.ncbi.nlm.nih.gov/pubmed/33578882
http://dx.doi.org/10.3390/pharmaceutics13020248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916551/
https://www.ncbi.nlm.nih.gov/pubmed/33578882
http://dx.doi.org/10.3390/pharmaceutics13020248

Ejemplares similares